首页> 外文期刊>Arthritis and Rheumatism >Azathioprine in the treatment of systemic lupus erythematosus. A controlled study
【24h】

Azathioprine in the treatment of systemic lupus erythematosus. A controlled study

机译:Azathioprine in the treatment of systemic lupus erythematosus. A controlled study

获取原文
           

摘要

AbstractSixteen patients with systemic lupus erythematosus have been observed for from 1 to 4 years while taking prednisone plus azathioprine in a dose of 2.5 mg/kg/day and compared to 19 patients with systemic lupus erythematosus managed with prednisone alone for a similar period. Patients receiving azathioprine showed a decreased mortality and morbidity, required less daily prednisone than the control group, exhibited no increased tendency to develop infection, had fewer exacerbations of their disease and maintained better renal function. Discontinuation of the azathioprine was associated with severe exacerbations of disease. The toxicity of azathioprine was minimal.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号